Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotatercept in pulmonary arterial hypertension
NCT03738150Phase 2Completed
- Start
- Apr 2019
- Primary completion
- Dec 2021
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of sotatercept in pulmonary arterial hypertension (PAH). Started Apr 2019; status: completed.
02
Drugs
sotatercept
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03738150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738150.